Evoke Pharma Asset Turnover 2012-2023 | EVOK
Evoke Pharma asset turnover from 2012 to 2023. Asset turnover can be defined as the amount of sales or revenues generated per dollar of assets. The asset turnover ratio is an indicator of the efficiency with which a company is deploying its assets.
| Evoke Pharma Asset Turnover Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.004B | $0.005B |
| Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $14.585B | 5.27 |
| Dr Reddy's Laboratories (RDY) | India | $11.835B | 18.71 |
| Aspen Pharmacare (APNHY) | South Africa | $4.900B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $4.401B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.128B | 2.44 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.004B | 13.71 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.656B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.439B | 0.00 |
| Generation Bio (GBIO) | United States | $0.199B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.074B | 0.00 |
| Personalis (PSNL) | United States | $0.066B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.026B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |